Zhejiang Yatai Pharmaceutical Co., Ltd. (SZSE: 002370)
Health Care · Pharmaceuticals · CN
CN¥5.16
+0.78% today · -17.3% 1Y
Zhejiang Yatai Pharmaceutical Co., Ltd. (SZSE: 002370) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $573.61M and employs 511 people.
Over the last twelve months the share price has lost 17.3%, trading between 4.41 and 9.41.
Tweenvest scores Zhejiang Yatai Pharmaceutical Co., Ltd. across four factors: quality 61/100, value 60/100, growth 0/100. Its strongest factor is quality.
002370 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $573.61M
- Revenue (TTM)
- $48.37M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 0.11
- 52-week high
- CN¥9.41
- 52-week low
- CN¥4.41
- Avg volume (3M)
- —
- Shares outstanding
- 745.67M
- Employees
- 511
- Next earnings
- —
About Zhejiang Yatai Pharmaceutical Co., Ltd.
Zhejiang Yatai Pharmaceutical Co., Ltd. operates across the entire pharmaceutical value chain, encompassing the research, development, manufacturing, sales, and global distribution of its medicinal products. The company's diverse product portfolio includes a variety of dosage forms, such as tablets, capsules, transdermal patches, powder for injection, and lozenges. Beyond finished pharmaceutical goods, Zhejiang Yatai also supplies chemical agents, essential raw materials, and diagnostic reagents. Furthermore, it extends its expertise to providing outsourced research and development services for the pharmaceutical industry. Established in 1989, Zhejiang Yatai Pharmaceutical Co., Ltd. is headquartered in Shaoxing, China.
- ISIN
- CNE100000MM5
- Founded
- 1989
- Listed since
- Mar 16, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Xiangxue Pharmaceutical Co.,Ltd.SZSE: 300147 | $581.64M | CN¥5.90 | +4.98% |
| Qianjiang Yongan Pharmaceutical Co., Ltd.SZSE: 002365 | $581.07M | CN¥13.48 | -2.53% |
| Middle East Pharmaceutical Industries CompanySASE: 4016 | $579.84M | SR62.20 | -3.12% |
| Xuanzhu Biopharmaceutical Co., Ltd.SEHK: 2575 | $579.19M | HK$8.78 | +6.75% |
| Zhejiang Starry Pharmaceutical Co.,Ltd.SHSE: 603520 | $571.88M | CN¥8.75 | +3.31% |
| Zhejiang Sunflower Great Health Co., Ltd.SZSE: 300111 | $571.85M | CN¥2.98 | -0.67% |
| Aquestive Therapeutics, Inc.NasdaqGM: AQST | $571.08M | $4.62 | +1.54% |
| Hainan Shuangcheng Pharmaceuticals Co., Ltd.SZSE: 002693 | $570.00M | CN¥9.22 | +2.67% |
Figures last refreshed Oct 4, 2026.